| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/20/2006 | CN1834090A Benzimidazole compounds, its prepn. and uses |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109337 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109314 Fluorescent nucleotides |
| 09/19/2006 | US7109259 Piperazinone derivatives |
| 09/19/2006 | US7109229 Methods and compounds for treating proliferative diseases |
| 09/19/2006 | US7109228 Pyrazole derivatives |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109204 Tyrosine kinase inhibitors |
| 09/19/2006 | US7109201 5-HT1D receptor antagonist activity; antidepressants |
| 09/19/2006 | US7109186 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 09/19/2006 | US7109185 Pharmaceutical formulations comprising indolinone derivatives |
| 09/19/2006 | US7109150 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/14/2006 | WO2006096785A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor |
| 09/14/2006 | WO2006096709A2 Process for preparing amorphous salts |
| 09/14/2006 | WO2006096564A1 Fused aromatic compounds having anti-diabetic activity |
| 09/14/2006 | WO2006095906A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | WO2006095810A1 Method for producing optically active helical polymer and polymerization initiator for optically active helical polymer |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095183A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | WO2006095159A1 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation |
| 09/14/2006 | WO2006095014A1 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | WO2006094691A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS |
| 09/14/2006 | WO2006062876A3 Estrogen receptor modulators |
| 09/14/2006 | WO2006051290A3 Compounds for treating protein-kinase mediated disorders |
| 09/14/2006 | WO2005112923A3 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205953 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 09/14/2006 | US20060205948 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders |
| 09/14/2006 | US20060205946 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205945 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/14/2006 | US20060205944 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/14/2006 | US20060205942 2-(2-Hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 09/14/2006 | US20060205941 Antiinflammatory agents; inflammatory bowel disorders |
| 09/14/2006 | US20060205802 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 09/14/2006 | US20060205801 Crystal and process for producing the same |
| 09/14/2006 | US20060205800 Glaucoma; prostaglandin EP2 receptor inhibitors |
| 09/14/2006 | US20060205797 Compounds for the treatment of inflammatory disorders |
| 09/14/2006 | US20060205791 Pharmaceutical process and compounds prepared thereby |
| 09/14/2006 | US20060205788 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205784 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205777 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205775 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-[2-((4-[4-(2-hydroxyethylcarbamoyl)piperidin-1-ylmethyl]benzoyl)methylamino)ethyl]piperidin-4-yl ester |
| 09/14/2006 | US20060205751 Novel compounds |
| 09/14/2006 | US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine |
| 09/14/2006 | US20060205740 Chemical compounds |
| 09/14/2006 | US20060205739 Aroylfuranes and aroylthiophenes |
| 09/14/2006 | US20060205738 Capped pyrazinoylguanidine sodium channel blockers |
| 09/14/2006 | US20060205735 Quinoline-4-carboxamide as NK-2 and NK-3 receptor antagonists |
| 09/14/2006 | US20060205728 Novel scaffolds for beta-helix mimicry |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | CA2601980A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | CA2601978A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor |
| 09/14/2006 | CA2600456A1 Process for preparing amorphous salts |
| 09/14/2006 | CA2600169A1 Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2599879A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | CA2599511A1 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/13/2006 | EP1700850A1 Novel phenylalanine derivative |
| 09/13/2006 | EP1699782A1 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 09/13/2006 | EP1699781A1 1-acetic acid-indole, -indazole and -benzimidazole derivatives useful for the treatment of respiratory disorders |
| 09/13/2006 | EP1699778A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 09/13/2006 | EP1699762A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| 09/13/2006 | EP1699761A1 Cb1 modulator compounds |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1699454A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 09/13/2006 | EP1699453A1 Cyclic guanidines, compositions containing such compounds and methods of use |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1345604B1 Use of a alpha-halogen-acryloyl distamycin derivate for the preparation of a medicament for the treatment of cancer |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832940A Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 09/13/2006 | CN1832939A Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/13/2006 | CN1832938A N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 09/13/2006 | CN1832929A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/13/2006 | CN1832928A 5-membered heterocycle-based p38 kinase inhibitors |
| 09/13/2006 | CN1832927A Novel gamma-secretase inhibitors |
| 09/13/2006 | CN1832921A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 09/13/2006 | CN1832742A Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 09/13/2006 | CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105563 5-ureido-3-[(4-(3-methoxyphenyl)pyrrol-2-yl)methylene]indolin-2-one and derivatives; inhibition of phosphoinositide-dependent kinase-1 (PDK-1). |
| 09/12/2006 | US7105562 2-methyl-6-[2-oxo-1,2-dihydro-indol-(3Z)-ylidene]1,4,5,6-tetrahydro-cyclopenta[b]pyrrole-3-carboxylic acid ethyl ester; disorders related to abnormal PK activity; |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105530 Pyrimidineamines as angiogenesis modulators |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |